Fate Therapeutics Inc. (FATE) NASDAQ

$55.96 1.37 (2.51%)

Market Cap: $5.34B

As of 12/08/21 04:00 PM EST. Market closed.

(FATE)

Fate Therapeutics Inc. (FATE) NASDAQ

$55.96 1.37 (2.51%)

Market Cap: $5.34B

As of 12/08/21 04:00 PM EST. Market closed.

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company's immuno-oncology product ... read more

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company's immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). The Company's immuno-regulatory product candidates include ProTmune™, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease. Fate Therapeutics is headquartered in San Diego, CA. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
William Rastetter
Full Time Employees
279
URL
Address
3535 General Atomics Ct Ste 200, California, San Diego, 92121-1140.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
William Rastetter
Full Time Employees
279
CEO Compensation (Base)
$516,000
Address
3535 General Atomics Ct Ste 200, California, San Diego, 92121-1140.
KEY STATS
Open
$0
Previous Close
$54.59
Days Range
$52 - $56.57
52 week range
$44.99 - $121.16
Volume
0
Avg. Volume (30 days)
939,257
Market Cap
$5.34B
Dividend Yield
0.00%
P/E
-27.18
Shares Outstanding
95,494,036
Open
$0
Previous Close
$54.59
Days Range
$52 - $56.57
52 week range
$44.99 - $121.16
Volume
0
Avg. Volume (30 days)
939,257
Market Cap
$5.34B
Dividend Yield
0.00%
P/E
-27.18
Shares Outstanding
95,494,036

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR FATE THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Wolchko J Scott President and CEO Nov 18, 2021 Option Exercise $2.70 20,000 54,000 413,793 Nov 22, 2021, 05:45 PM
Wolchko J Scott President and CEO Nov 18, 2021 Sale $54.27 20,000 1,085,400 393,793 Nov 22, 2021, 05:45 PM
Wolchko J Scott President and CEO Oct 21, 2021 Option Exercise $2.73 30,000 81,900 423,793 Oct 25, 2021, 04:04 PM
Wolchko J Scott President and CEO Oct 22, 2021 Option Exercise $3.06 30,000 91,670 423,793 Oct 25, 2021, 04:04 PM
Wolchko J Scott President and CEO Oct 21, 2021 Sale $60.22 30,000 1,806,560 408,558 Oct 25, 2021, 04:04 PM
Wolchko J Scott President and CEO Oct 22, 2021 Sale $58.88 30,000 1,766,400 393,793 Oct 25, 2021, 04:04 PM
TAHL CINDY General Counsel and Secretary Oct 01, 2021 Option Exercise $6.55 50,000 327,500 158,048 Oct 04, 2021, 04:12 PM
TAHL CINDY General Counsel and Secretary Oct 01, 2021 Sale $58.83 50,000 2,941,462 141,736 Oct 04, 2021, 04:12 PM
Dulac Edward J III Chief Financial Officer Sep 28, 2021 Option Exercise $35.52 17,325 615,384 71,864 Sep 30, 2021, 04:14 PM
Dulac Edward J III Chief Financial Officer Sep 28, 2021 Sale $62.53 19,460 1,216,834 52,404 Sep 30, 2021, 04:14 PM
Valamehr Bahram Chief Development Officer Sep 13, 2021 Option Exercise $2.73 25,000 68,250 120,740 Sep 14, 2021, 04:01 PM
Valamehr Bahram Chief Development Officer Sep 13, 2021 Sale $66.29 25,000 1,657,257 104,931 Sep 14, 2021, 04:01 PM
Wolchko J Scott President and CEO Aug 19, 2021 Option Exercise $4.84 20,000 96,700 413,793 Aug 20, 2021, 04:02 PM
Wolchko J Scott President and CEO Aug 19, 2021 Sale $88.01 20,000 1,760,204 393,793 Aug 20, 2021, 04:02 PM
Dulac Edward J III Chief Financial Officer Aug 19, 2021 Sale $88.26 3,474 306,602 56,076 Aug 20, 2021, 04:01 PM
Wolchko J Scott President and CEO Jul 23, 2021 Option Exercise $4.14 30,000 124,100 423,793 Jul 26, 2021, 04:05 PM
Wolchko J Scott President and CEO Jul 22, 2021 Option Exercise $2.73 30,000 81,900 423,793 Jul 26, 2021, 04:05 PM
Wolchko J Scott President and CEO Jul 22, 2021 Sale $86.05 30,000 2,581,575 417,166 Jul 26, 2021, 04:05 PM
Wolchko J Scott President and CEO Jul 23, 2021 Sale $85.28 30,000 2,558,538 393,793 Jul 26, 2021, 04:05 PM
TAHL CINDY General Counsel and Secretary Jul 01, 2021 Option Exercise $5.64 55,534 313,242 163,582 Jul 02, 2021, 07:08 PM
TAHL CINDY General Counsel and Secretary Jul 01, 2021 Sale $85.24 55,534 4,733,743 163,482 Jul 02, 2021, 07:08 PM
Chu Yu-Waye Senior VP Clinical Development Apr 16, 2021 Sale $83.30 3,275 272,809 67,200 Apr 20, 2021, 04:00 PM
TAHL CINDY See Remarks Apr 01, 2021 Option Exercise $3.21 30,000 96,199 138,048 Apr 02, 2021, 06:03 PM
TAHL CINDY See Remarks Apr 01, 2021 Sale $83.81 30,000 2,514,329 137,048 Apr 02, 2021, 06:03 PM
Valamehr Bahram Chief Development Officer Mar 15, 2021 Option Exercise $2.90 25,000 72,500 120,740 Mar 16, 2021, 04:05 PM
Valamehr Bahram Chief Development Officer Mar 15, 2021 Sale $92.35 25,000 2,308,772 116,783 Mar 16, 2021, 04:05 PM
Shoemaker Daniel D Chief Scientific Officer Mar 08, 2021 Sale $81.74 25,000 2,043,428 94,722 Mar 09, 2021, 04:02 PM
Wolchko J Scott President and CEO Feb 18, 2021 Option Exercise $6.62 20,000 132,400 413,793 Feb 19, 2021, 04:07 PM
Wolchko J Scott President and CEO Feb 18, 2021 Sale $102.01 20,000 2,040,258 412,392 Feb 19, 2021, 04:07 PM
Wolchko J Scott President and CEO Jan 21, 2021 Option Exercise $2.73 30,000 81,900 423,793 Jan 22, 2021, 06:23 PM
Wolchko J Scott President and CEO Jan 22, 2021 Option Exercise $5.32 30,000 159,700 423,793 Jan 22, 2021, 06:23 PM
Wolchko J Scott President and CEO Jan 22, 2021 Sale $98.29 30,000 2,948,612 411,026 Jan 22, 2021, 06:23 PM
Wolchko J Scott President and CEO Jan 21, 2021 Sale $103.05 30,000 3,091,357 421,253 Jan 22, 2021, 06:23 PM
TAHL CINDY General Counsel and Secretary Jan 19, 2021 Option Exercise $2.90 35,000 101,500 125,035 Jan 21, 2021, 07:08 PM
TAHL CINDY General Counsel and Secretary Jan 19, 2021 Sale $114.76 35,000 4,016,639 109,200 Jan 21, 2021, 07:08 PM
Wolchko J Scott President and CEO Jan 11, 2021 Sale $110.81 8,587 951,556 355,634 Jan 12, 2021, 08:41 PM
Wolchko J Scott President and CEO Jan 08, 2021 Sale $117.10 60,820 7,122,217 393,065 Jan 12, 2021, 08:41 PM
Valamehr Bahram Chief Development Officer Jan 08, 2021 Sale $117.10 6,230 729,552 84,455 Jan 12, 2021, 08:40 PM
Valamehr Bahram Chief Development Officer Jan 11, 2021 Sale $110.81 3,254 360,588 79,649 Jan 12, 2021, 08:40 PM
TAHL CINDY General Counsel and Secretary Jan 11, 2021 Sale $110.81 3,254 360,587 91,957 Jan 12, 2021, 08:39 PM
TAHL CINDY General Counsel and Secretary Jan 08, 2021 Sale $117.10 6,229 729,434 96,763 Jan 12, 2021, 08:39 PM
Shoemaker Daniel D Chief Scientific Officer Jan 08, 2021 Sale $117.10 6,229 729,434 90,336 Jan 12, 2021, 08:38 PM
Shoemaker Daniel D Chief Scientific Officer Jan 11, 2021 Sale $110.81 3,253 360,477 85,530 Jan 12, 2021, 08:38 PM
Redmile Group, LLC Director Jan 08, 2021 Buy $85.50 327,485 27,999,968 12,957,222 Jan 12, 2021, 04:16 PM
Wolchko J Scott President and CEO Dec 17, 2020 Option Exercise $6.62 20,000 132,400 439,969 Dec 18, 2020, 04:01 PM
Wolchko J Scott President and CEO Dec 17, 2020 Sale $91.82 20,000 1,836,352 436,801 Dec 18, 2020, 04:01 PM
Valamehr Bahram Chief Development Officer Dec 14, 2020 Option Exercise $2.90 25,000 72,500 112,211 Dec 15, 2020, 04:01 PM
Valamehr Bahram Chief Development Officer Dec 14, 2020 Sale $97.78 25,000 2,444,477 110,398 Dec 15, 2020, 04:01 PM
Shoemaker Daniel D Chief Scientific Officer Nov 16, 2020 Sale $51.83 25,000 1,295,746 113,159 Nov 16, 2020, 05:12 PM
Wolchko J Scott President and CEO Nov 12, 2020 Option Exercise $2.73 30,000 81,900 449,969 Nov 16, 2020, 04:02 PM
Wolchko J Scott President and CEO Nov 13, 2020 Option Exercise $5.73 30,000 172,007 430,123 Nov 16, 2020, 04:02 PM
Wolchko J Scott President and CEO Nov 13, 2020 Sale $51.03 30,000 1,530,900 419,969 Nov 16, 2020, 04:02 PM
Wolchko J Scott President and CEO Nov 12, 2020 Sale $52.72 30,000 1,581,524 434,767 Nov 16, 2020, 04:02 PM
TAHL CINDY General Counsel and Secretary Nov 04, 2020 Option Exercise $2.73 51,519 140,647 151,037 Nov 06, 2020, 04:02 PM
TAHL CINDY General Counsel and Secretary Nov 05, 2020 Option Exercise $2.82 19,282 54,340 118,800 Nov 06, 2020, 04:02 PM
TAHL CINDY General Counsel and Secretary Nov 05, 2020 Sale $50.63 19,282 976,252 102,118 Nov 06, 2020, 04:02 PM
TAHL CINDY General Counsel and Secretary Nov 04, 2020 Sale $50.41 51,519 2,597,140 99,518 Nov 06, 2020, 04:02 PM
TAHL CINDY General Counsel and Secretary Oct 16, 2020 Option Exercise $2.73 29,199 79,713 128,717 Oct 20, 2020, 04:01 PM
TAHL CINDY General Counsel and Secretary Oct 16, 2020 Sale $50.25 29,199 1,467,212 99,518 Oct 20, 2020, 04:01 PM
TAHL CINDY General Counsel and Secretary Oct 01, 2020 Option Exercise $2.73 35,000 95,550 134,518 Oct 02, 2020, 12:00 AM
TAHL CINDY General Counsel and Secretary Oct 01, 2020 Sale $40.74 35,000 1,426,065 112,761 Oct 02, 2020, 12:00 AM
Valamehr Bahram Chief Development Officer Sep 14, 2020 Option Exercise $2.75 25,000 68,778 112,211 Sep 16, 2020, 04:02 PM
Valamehr Bahram Chief Development Officer Sep 14, 2020 Sale $36.28 25,000 907,024 111,611 Sep 16, 2020, 04:02 PM
Shoemaker Daniel D Chief Scientific Officer Sep 14, 2020 Sale $36.30 25,000 907,540 141,691 Sep 16, 2020, 04:01 PM
Redmile Group, LLC Director Jun 11, 2020 Buy $28.31 1,412,928 39,999,991 12,629,737 Jun 17, 2020, 08:25 PM
RASTETTER WILLIAM H Director Mar 30, 2020 Option Exercise $1.37 28,461 38,992 28,461 Mar 31, 2020, 04:01 PM
Valamehr Bahram Chief Development Officer Feb 03, 2020 Option Exercise $1.69 1,153 1,949 87,211 Feb 04, 2020, 12:00 AM
Wolchko J Scott President and CEO Jan 30, 2020 Option Exercise $2.70 25,000 67,500 444,969 Feb 03, 2020, 04:01 PM
Wolchko J Scott President and CEO Jan 30, 2020 Sale $25.45 25,000 636,303 419,969 Feb 03, 2020, 04:01 PM
Valamehr Bahram Chief Development Officer Jan 08, 2020 Sale $20.69 5,700 117,947 86,058 Jan 10, 2020, 04:03 PM
TAHL CINDY General Counsel and Secretary Jan 08, 2020 Sale $20.72 5,700 118,085 99,518 Jan 10, 2020, 04:02 PM
Shoemaker Daniel D Chief Scientific Officer Jan 08, 2020 Sale $20.70 5,700 117,986 143,091 Jan 10, 2020, 04:01 PM
Shoemaker Daniel D Chief Scientific Officer Dec 30, 2019 Option Exercise $2.90 25,000 72,500 148,791 Jan 02, 2020, 04:01 PM
Shoemaker Daniel D Chief Scientific Officer Dec 30, 2019 Sale $19.50 25,000 487,427 123,891 Jan 02, 2020, 04:01 PM
Wolchko J Scott President and CEO Dec 19, 2019 Option Exercise $2.70 25,000 67,500 378,969 Dec 23, 2019, 04:02 PM
Wolchko J Scott President and CEO Dec 20, 2019 Option Exercise $2.70 25,000 67,500 378,969 Dec 23, 2019, 04:02 PM
Wolchko J Scott President and CEO Dec 19, 2019 Sale $20.08 25,000 501,897 353,969 Dec 23, 2019, 04:02 PM
Wolchko J Scott President and CEO Dec 20, 2019 Sale $20.17 25,000 504,157 353,969 Dec 23, 2019, 04:02 PM
Wolchko J Scott President and CEO Oct 15, 2019 Sale $14.44 21,017 303,458 353,969 Oct 16, 2019, 04:07 PM
Valamehr Bahram Chief Development Officer Oct 15, 2019 Sale $14.18 6,200 87,891 66,758 Oct 16, 2019, 04:06 PM
TAHL CINDY General Counsel and Secretary Oct 15, 2019 Sale $14.24 10,200 145,292 80,218 Oct 16, 2019, 04:05 PM
Shoemaker Daniel D Chief Scientific Officer Oct 15, 2019 Sale $14.29 11,800 168,593 123,791 Oct 16, 2019, 04:04 PM
Redmile Group, LLC Director Sep 16, 2019 Buy $17.50 857,143 15,000,003 11,216,809 Sep 17, 2019, 04:22 PM
Nashat Amir Director Jul 31, 2019 Sale $22.53 31,139 701,674 1,129,554 Aug 02, 2019, 04:32 PM
Nashat Amir Director Aug 01, 2019 Sale $22.53 30,866 695,392 1,099,772 Aug 02, 2019, 04:32 PM
Nashat Amir Director Jul 30, 2019 Sale $22.51 90,175 2,029,560 1,159,599 Jul 30, 2019, 06:25 PM
Nashat Amir Director Jul 29, 2019 Sale $22.50 329 7,403 1,246,609 Jul 30, 2019, 06:25 PM
Nashat Amir Director Jul 26, 2019 Sale $22.50 27,829 626,153 1,246,926 Jul 30, 2019, 06:25 PM
Nashat Amir Director Jul 24, 2019 Sale $22.51 19,866 447,098 1,273,778 Jul 25, 2019, 06:24 PM
Nashat Amir Director Jul 23, 2019 Sale $22.50 62,033 1,396,053 1,292,946 Jul 25, 2019, 06:24 PM
Nashat Amir Director Jul 18, 2019 Sale $22.50 21,409 481,795 1,400,808 Jul 22, 2019, 05:52 PM
Nashat Amir Director Jul 22, 2019 Sale $22.52 48,704 1,097,019 1,352,800 Jul 22, 2019, 05:52 PM
Nashat Amir Director Jul 19, 2019 Sale $22.50 1,053 23,693 1,399,792 Jul 22, 2019, 05:52 PM
Shoemaker Daniel D Chief Scientific Officer Jun 27, 2019 Option Exercise $2.90 12,500 36,250 148,091 Jun 28, 2019, 04:02 PM
Shoemaker Daniel D Chief Scientific Officer Jun 27, 2019 Sale $20.21 12,500 252,610 135,591 Jun 28, 2019, 04:02 PM
Wolchko J Scott President and CEO May 16, 2019 Option Exercise $1.63 14,335 23,366 389,216 May 17, 2019, 06:27 PM
Wolchko J Scott President and CEO May 16, 2019 Sale $19.37 14,335 277,684 386,918 May 17, 2019, 06:27 PM
Wolchko J Scott President and CEO Apr 17, 2019 Option Exercise $1.63 8,541 13,922 382,330 Apr 19, 2019, 04:13 PM
Wolchko J Scott President and CEO Apr 18, 2019 Option Exercise $1.63 11,459 18,678 381,724 Apr 19, 2019, 04:13 PM
Wolchko J Scott President and CEO Apr 18, 2019 Sale $16.01 11,459 183,509 374,881 Apr 19, 2019, 04:13 PM
Wolchko J Scott President and CEO Apr 17, 2019 Sale $16.17 8,541 138,132 374,881 Apr 19, 2019, 04:13 PM
Shoemaker Daniel D Chief Scientific Officer Mar 28, 2019 Option Exercise $2.90 12,500 36,250 148,091 Mar 29, 2019, 04:01 PM
Shoemaker Daniel D Chief Scientific Officer Mar 28, 2019 Sale $16.94 12,500 211,702 135,591 Mar 29, 2019, 04:01 PM
Wolchko J Scott President and CEO Mar 21, 2019 Option Exercise $1.63 20,000 32,600 394,881 Mar 22, 2019, 04:01 PM
Wolchko J Scott President and CEO Mar 21, 2019 Sale $17.61 20,000 352,160 374,881 Mar 22, 2019, 04:01 PM
TAHL CINDY General Counsel and Secretary Mar 01, 2019 Option Exercise $2.90 25,000 72,500 115,418 Mar 05, 2019, 09:00 AM
TAHL CINDY General Counsel and Secretary Mar 01, 2019 Sale $16.15 25,000 403,697 90,418 Mar 05, 2019, 09:00 AM
TAHL CINDY General Counsel and Secretary Feb 25, 2019 Option Exercise $2.90 25,000 72,500 115,418 Feb 27, 2019, 04:01 PM
TAHL CINDY General Counsel and Secretary Feb 25, 2019 Sale $16.07 25,000 401,820 90,418 Feb 27, 2019, 04:01 PM
Nashat Amir Director Jan 30, 2019 Sale $14.16 53,017 750,959 1,474,979 Feb 01, 2019, 05:02 PM
Nashat Amir Director Jan 29, 2019 Sale $14.16 97,500 1,380,795 1,529,622 Jan 31, 2019, 06:00 PM
Nashat Amir Director Jan 28, 2019 Sale $13.78 70,000 964,768 1,626,157 Jan 30, 2019, 04:10 PM
Nashat Amir Director Jan 25, 2019 Sale $14.14 90,000 1,272,753 1,696,859 Jan 29, 2019, 04:31 PM
Nashat Amir Director Jan 18, 2019 Sale $16.28 39,483 642,834 1,785,088 Jan 23, 2019, 04:32 PM
TAHL CINDY General Counsel and Secretary Jan 07, 2019 Option Exercise $2.27 25,000 56,673 70,418 Jan 09, 2019, 04:03 PM
TAHL CINDY General Counsel and Secretary Jan 07, 2019 Sale $16.00 25,000 400,000 45,418 Jan 09, 2019, 04:03 PM
Nashat Amir Director Dec 20, 2018 Sale $12.25 33,474 410,160 1,824,360 Dec 26, 2018, 04:13 PM
Nashat Amir Director Dec 19, 2018 Sale $13.40 91,210 1,222,592 1,882,881 Dec 21, 2018, 04:12 PM
Nashat Amir Director Dec 13, 2018 Sale $16.67 17,788 296,563 1,948,494 Dec 17, 2018, 04:25 PM
Nashat Amir Director Dec 12, 2018 Sale $16.78 425,000 7,132,690 1,980,561 Dec 14, 2018, 04:33 PM
Nashat Amir Director Dec 11, 2018 Sale $16.71 82,528 1,379,183 2,393,552 Dec 13, 2018, 05:14 PM
Redmile Group, LLC Director Sep 25, 2018 Buy $13.50 3,703,704 50,000,004 10,359,666 Sep 27, 2018, 04:23 PM
ABBOT STEWART Chief Development Officer May 15, 2018 Option Exercise $6.62 21,054 139,411 64,917 May 16, 2018, 05:28 PM
Wolchko J Scott President and CEO Oct 16, 2017 Sale $4.07 800 3,256 124,881 Oct 17, 2017, 04:05 PM
Wolchko J Scott President and CEO Oct 13, 2017 Sale $3.87 16,368 63,344 125,681 Oct 17, 2017, 04:05 PM
TAHL CINDY General Counsel and Secretary Oct 13, 2017 Sale $3.83 7,591 29,074 45,918 Oct 17, 2017, 04:04 PM
TAHL CINDY General Counsel and Secretary Oct 16, 2017 Sale $4.10 500 2,050 45,418 Oct 17, 2017, 04:04 PM
Shoemaker Daniel D Chief Scientific Officer Oct 13, 2017 Sale $3.86 12,525 48,346 91,291 Oct 17, 2017, 04:04 PM
Shoemaker Daniel D Chief Scientific Officer Oct 16, 2017 Sale $4.08 700 2,856 90,591 Oct 17, 2017, 04:04 PM
Storgard Chris Chief Medical Officer Nov 23, 2016 Buy $2.66 37,593 99,997 37,593 Nov 28, 2016, 03:46 PM
RASTETTER WILLIAM H Director Nov 23, 2016 Buy $2.66 375,939 999,998 459,272 Nov 28, 2016, 03:44 PM
Coughlin Timothy P Director Nov 23, 2016 Buy $2.66 56,390 149,997 56,390 Nov 28, 2016, 03:42 PM
Wolchko J Scott President and CEO Aug 23, 2016 Option Exercise $1.37 2,570 3,521 142,049 Aug 24, 2016, 06:55 PM
Wolchko J Scott President and CEO Jan 18, 2016 Option Exercise $1.50 7,500 11,238 139,479 Jan 20, 2016, 02:32 PM
Wolchko J Scott See Remarks Apr 13, 2015 Option Exercise $1.47 8,000 11,723 34,773 Apr 14, 2015, 04:22 PM
Weyer Christian See Remarks Apr 13, 2015 Option Exercise $1.37 25,000 34,250 30,429 Apr 14, 2015, 03:52 PM
Flynn Peter D See remarks Jun 11, 2014 Option Exercise $1.63 1,017 1,658 5,056 Jun 12, 2014, 05:45 PM
Flynn Peter D See remarks Jun 12, 2014 Option Exercise $1.61 5,471 8,808 9,510 Jun 12, 2014, 05:45 PM
Flynn Peter D See remarks Jun 11, 2014 Sale $7.00 1,017 7,119 4,039 Jun 12, 2014, 05:45 PM
Flynn Peter D See remarks Jun 12, 2014 Sale $7.00 5,471 38,297 4,039 Jun 12, 2014, 05:45 PM
Flynn Peter D See remarks Jun 10, 2014 Option Exercise $1.63 699 1,139 5,389 Jun 11, 2014, 05:58 PM
Flynn Peter D See remarks Jun 09, 2014 Option Exercise $1.63 1,260 2,054 6,645 Jun 11, 2014, 05:58 PM
Flynn Peter D See remarks Jun 10, 2014 Sale $7.00 1,350 9,450 4,039 Jun 11, 2014, 05:58 PM
Flynn Peter D See remarks Jun 09, 2014 Sale $7.00 1,955 13,685 4,690 Jun 11, 2014, 05:58 PM
Flynn Peter D See remarks May 01, 2014 Option Exercise $1.62 25,341 40,977 15,178 May 05, 2014, 05:48 PM
Flynn Peter D See remarks May 01, 2014 Sale $7.07 29,379 207,598 5,385 May 05, 2014, 05:48 PM
Flynn Peter D See remarks Apr 04, 2014 Option Exercise $1.63 5,889 9,599 12,620 Apr 07, 2014, 12:39 PM
Flynn Peter D See remarks Apr 04, 2014 Sale $8.00 5,889 47,109 6,831 Apr 07, 2014, 12:39 PM
Wolchko J Scott See remarks Apr 03, 2014 Option Exercise $1.37 8,862 12,141 23,888 Apr 07, 2014, 12:32 PM
Weyer Christian See remarks Apr 01, 2014 Option Exercise $1.37 7,738 10,601 7,738 Apr 03, 2014, 12:55 PM
Weyer Christian See remarks Apr 02, 2014 Option Exercise $1.37 2,262 3,099 2,262 Apr 03, 2014, 12:55 PM
Weyer Christian See remarks Apr 02, 2014 Sale $9.02 2,262 20,395 0 Apr 03, 2014, 12:55 PM
Weyer Christian See remarks Apr 01, 2014 Sale $9.02 7,738 69,789 0 Apr 03, 2014, 12:55 PM
Shoemaker Daniel D Chief Technology Officer Mar 31, 2014 Sale $9.86 8,653 85,361 26,362 Apr 02, 2014, 12:07 PM
Flynn Peter D See remarks Apr 01, 2014 Sale $9.05 1,346 12,177 6,731 Apr 02, 2014, 12:00 PM
Flynn Peter D See remarks Mar 31, 2014 Sale $10.16 2,692 27,348 8,377 Apr 02, 2014, 12:00 PM
Wolchko J Scott See remarks Apr 01, 2014 Sale $9.08 4,019 36,482 15,026 Apr 02, 2014, 11:52 AM
Wolchko J Scott See remarks Mar 31, 2014 Sale $9.79 15,981 156,397 19,545 Apr 02, 2014, 11:52 AM
VENROCK ASSOCIATES V LP 10% Owner Oct 04, 2013 Option Exercise $6.00 128,447 770,682 1,639,854 Oct 07, 2013, 04:18 PM
VENROCK ASSOCIATES V LP 10% Owner Oct 04, 2013 Buy $6.00 833,333 4,999,998 2,473,187 Oct 07, 2013, 04:18 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Oct 04, 2013 Option Exercise $6.00 1,239 7,434 1,639,853 Oct 07, 2013, 02:17 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Oct 04, 2013 Option Exercise $6.00 849 5,094 1,638,614 Oct 07, 2013, 02:17 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Oct 04, 2013 Option Exercise $6.00 2,415 14,490 1,637,765 Oct 07, 2013, 02:17 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Oct 04, 2013 Option Exercise $6.00 123,943 743,658 1,635,350 Oct 07, 2013, 02:17 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Oct 04, 2013 Buy $6.00 8,041 48,246 2,473,186 Oct 07, 2013, 02:17 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Oct 04, 2013 Buy $6.00 5,508 33,048 2,465,145 Oct 07, 2013, 02:17 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Oct 04, 2013 Buy $6.00 15,672 94,032 2,459,637 Oct 07, 2013, 02:17 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Oct 04, 2013 Buy $6.00 804,112 4,824,672 2,443,965 Oct 07, 2013, 02:17 PM
Nashat Amir Director Oct 04, 2013 Option Exercise $6.00 1,239 7,434 1,639,853 Oct 07, 2013, 02:07 PM
Nashat Amir Director Oct 04, 2013 Option Exercise $6.00 849 5,094 1,638,614 Oct 07, 2013, 02:07 PM
Nashat Amir Director Oct 04, 2013 Option Exercise $6.00 2,415 14,490 1,637,765 Oct 07, 2013, 02:07 PM
Nashat Amir Director Oct 04, 2013 Option Exercise $6.00 123,943 743,658 1,635,350 Oct 07, 2013, 02:07 PM
Nashat Amir Director Oct 04, 2013 Buy $6.00 8,041 48,246 2,473,186 Oct 07, 2013, 02:07 PM
Nashat Amir Director Oct 04, 2013 Buy $6.00 5,508 33,048 2,465,145 Oct 07, 2013, 02:07 PM
Nashat Amir Director Oct 04, 2013 Buy $6.00 15,672 94,032 2,459,637 Oct 07, 2013, 02:07 PM
Nashat Amir Director Oct 04, 2013 Buy $6.00 804,112 4,824,672 2,443,965 Oct 07, 2013, 02:07 PM
OVP VENTURE PARTNERS VII LP 10% Owner Oct 04, 2013 Option Exercise $6.00 822 4,932 1,499,467 Oct 07, 2013, 02:06 PM
OVP VENTURE PARTNERS VII LP 10% Owner Oct 04, 2013 Option Exercise $6.00 116,629 699,774 1,498,645 Oct 07, 2013, 02:06 PM
ARCH VENTURE FUND VI LP 10% Owner Oct 04, 2013 Option Exercise $6.00 128,447 770,682 1,639,855 Oct 07, 2013, 02:06 PM
ARCH VENTURE FUND VI LP 10% Owner Oct 04, 2013 Buy $6.00 833,333 4,999,998 2,473,188 Oct 07, 2013, 02:06 PM
NELSEN ROBERT Director Oct 04, 2013 Option Exercise $6.00 128,447 770,682 1,639,855 Oct 07, 2013, 02:00 PM
NELSEN ROBERT Director Oct 04, 2013 Buy $6.00 833,333 4,999,998 2,473,188 Oct 07, 2013, 02:00 PM
RASTETTER WILLIAM H Director Oct 04, 2013 Buy $6.00 83,333 499,998 83,333 Oct 07, 2013, 01:59 PM
MENDLEIN JOHN Director Oct 04, 2013 Buy $6.00 16,667 100,002 156,774 Oct 07, 2013, 01:59 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Wolchko J Scott President and CEO 11/18/2021 54,000
Wolchko J Scott President and CEO 11/18/2021 1,085,400
Wolchko J Scott President and CEO 10/21/2021 81,900
Wolchko J Scott President and CEO 10/22/2021 91,670
Wolchko J Scott President and CEO 10/21/2021 1,806,560
Wolchko J Scott President and CEO 10/22/2021 1,766,400
TAHL CINDY General Counsel and Secretary 10/01/2021 327,500
TAHL CINDY General Counsel and Secretary 10/01/2021 2,941,462
Dulac Edward J III Chief Financial Officer 09/28/2021 615,384
Dulac Edward J III Chief Financial Officer 09/28/2021 1,216,834
Valamehr Bahram Chief Development Officer 09/13/2021 68,250
Valamehr Bahram Chief Development Officer 09/13/2021 1,657,257
Wolchko J Scott President and CEO 08/19/2021 96,700
Wolchko J Scott President and CEO 08/19/2021 1,760,204
Dulac Edward J III Chief Financial Officer 08/19/2021 306,602
Wolchko J Scott President and CEO 07/23/2021 124,100
Wolchko J Scott President and CEO 07/22/2021 81,900
Wolchko J Scott President and CEO 07/22/2021 2,581,575
Wolchko J Scott President and CEO 07/23/2021 2,558,538
TAHL CINDY General Counsel and Secretary 07/01/2021 313,242
TAHL CINDY General Counsel and Secretary 07/01/2021 4,733,743
Chu Yu-Waye Senior VP Clinical Development 04/16/2021 272,809
TAHL CINDY See Remarks 04/01/2021 96,199
TAHL CINDY See Remarks 04/01/2021 2,514,329
Valamehr Bahram Chief Development Officer 03/15/2021 72,500
Valamehr Bahram Chief Development Officer 03/15/2021 2,308,772
Shoemaker Daniel D Chief Scientific Officer 03/08/2021 2,043,428
Wolchko J Scott President and CEO 02/18/2021 132,400
Wolchko J Scott President and CEO 02/18/2021 2,040,258
Wolchko J Scott President and CEO 01/21/2021 81,900
Wolchko J Scott President and CEO 01/22/2021 159,700
Wolchko J Scott President and CEO 01/22/2021 2,948,612
Wolchko J Scott President and CEO 01/21/2021 3,091,357
TAHL CINDY General Counsel and Secretary 01/19/2021 101,500
TAHL CINDY General Counsel and Secretary 01/19/2021 4,016,639
Wolchko J Scott President and CEO 01/11/2021 951,556
Wolchko J Scott President and CEO 01/08/2021 7,122,217
Valamehr Bahram Chief Development Officer 01/08/2021 729,552
Valamehr Bahram Chief Development Officer 01/11/2021 360,588
TAHL CINDY General Counsel and Secretary 01/11/2021 360,587
TAHL CINDY General Counsel and Secretary 01/08/2021 729,434
Shoemaker Daniel D Chief Scientific Officer 01/08/2021 729,434
Shoemaker Daniel D Chief Scientific Officer 01/11/2021 360,477
Redmile Group, LLC Director 01/08/2021 27,999,968
Wolchko J Scott President and CEO 12/17/2020 132,400
Wolchko J Scott President and CEO 12/17/2020 1,836,352
Valamehr Bahram Chief Development Officer 12/14/2020 72,500
Valamehr Bahram Chief Development Officer 12/14/2020 2,444,477
Shoemaker Daniel D Chief Scientific Officer 11/16/2020 1,295,746
Wolchko J Scott President and CEO 11/12/2020 81,900
Wolchko J Scott President and CEO 11/13/2020 172,007
Wolchko J Scott President and CEO 11/13/2020 1,530,900
Wolchko J Scott President and CEO 11/12/2020 1,581,524
TAHL CINDY General Counsel and Secretary 11/04/2020 140,647
TAHL CINDY General Counsel and Secretary 11/05/2020 54,340
TAHL CINDY General Counsel and Secretary 11/05/2020 976,252
TAHL CINDY General Counsel and Secretary 11/04/2020 2,597,140
TAHL CINDY General Counsel and Secretary 10/16/2020 79,713
TAHL CINDY General Counsel and Secretary 10/16/2020 1,467,212
TAHL CINDY General Counsel and Secretary 10/01/2020 95,550
TAHL CINDY General Counsel and Secretary 10/01/2020 1,426,065
Valamehr Bahram Chief Development Officer 09/14/2020 68,778
Valamehr Bahram Chief Development Officer 09/14/2020 907,024
Shoemaker Daniel D Chief Scientific Officer 09/14/2020 907,540
Redmile Group, LLC Director 06/11/2020 39,999,991
RASTETTER WILLIAM H Director 03/30/2020 38,992
Valamehr Bahram Chief Development Officer 02/03/2020 1,949
Wolchko J Scott President and CEO 01/30/2020 67,500
Wolchko J Scott President and CEO 01/30/2020 636,303
Valamehr Bahram Chief Development Officer 01/08/2020 117,947
TAHL CINDY General Counsel and Secretary 01/08/2020 118,085
Shoemaker Daniel D Chief Scientific Officer 01/08/2020 117,986
Shoemaker Daniel D Chief Scientific Officer 12/30/2019 72,500
Shoemaker Daniel D Chief Scientific Officer 12/30/2019 487,427
Wolchko J Scott President and CEO 12/19/2019 67,500
Wolchko J Scott President and CEO 12/20/2019 67,500
Wolchko J Scott President and CEO 12/19/2019 501,897
Wolchko J Scott President and CEO 12/20/2019 504,157
Wolchko J Scott President and CEO 10/15/2019 303,458
Valamehr Bahram Chief Development Officer 10/15/2019 87,891
TAHL CINDY General Counsel and Secretary 10/15/2019 145,292
Shoemaker Daniel D Chief Scientific Officer 10/15/2019 168,593
Redmile Group, LLC Director 09/16/2019 15,000,003
Nashat Amir Director 07/31/2019 701,674
Nashat Amir Director 08/01/2019 695,392
Nashat Amir Director 07/30/2019 2,029,560
Nashat Amir Director 07/29/2019 7,403
Nashat Amir Director 07/26/2019 626,153
Nashat Amir Director 07/24/2019 447,098
Nashat Amir Director 07/23/2019 1,396,053
Nashat Amir Director 07/18/2019 481,795
Nashat Amir Director 07/22/2019 1,097,019
Nashat Amir Director 07/19/2019 23,693
Shoemaker Daniel D Chief Scientific Officer 06/27/2019 36,250
Shoemaker Daniel D Chief Scientific Officer 06/27/2019 252,610
Wolchko J Scott President and CEO 05/16/2019 23,366
Wolchko J Scott President and CEO 05/16/2019 277,684
Wolchko J Scott President and CEO 04/17/2019 13,922
Wolchko J Scott President and CEO 04/18/2019 18,678
Wolchko J Scott President and CEO 04/18/2019 183,509
Wolchko J Scott President and CEO 04/17/2019 138,132
Shoemaker Daniel D Chief Scientific Officer 03/28/2019 36,250
Shoemaker Daniel D Chief Scientific Officer 03/28/2019 211,702
Wolchko J Scott President and CEO 03/21/2019 32,600
Wolchko J Scott President and CEO 03/21/2019 352,160
TAHL CINDY General Counsel and Secretary 03/01/2019 72,500
TAHL CINDY General Counsel and Secretary 03/01/2019 403,697
TAHL CINDY General Counsel and Secretary 02/25/2019 72,500
TAHL CINDY General Counsel and Secretary 02/25/2019 401,820
Nashat Amir Director 01/30/2019 750,959
Nashat Amir Director 01/29/2019 1,380,795
Nashat Amir Director 01/28/2019 964,768
Nashat Amir Director 01/25/2019 1,272,753
Nashat Amir Director 01/18/2019 642,834
TAHL CINDY General Counsel and Secretary 01/07/2019 56,673
TAHL CINDY General Counsel and Secretary 01/07/2019 400,000
Nashat Amir Director 12/20/2018 410,160
Nashat Amir Director 12/19/2018 1,222,592
Nashat Amir Director 12/13/2018 296,563
Nashat Amir Director 12/12/2018 7,132,690
Nashat Amir Director 12/11/2018 1,379,183
Redmile Group, LLC Director 09/25/2018 50,000,004
ABBOT STEWART Chief Development Officer 05/15/2018 139,411
Wolchko J Scott President and CEO 10/16/2017 3,256
Wolchko J Scott President and CEO 10/13/2017 63,344
TAHL CINDY General Counsel and Secretary 10/13/2017 29,074
TAHL CINDY General Counsel and Secretary 10/16/2017 2,050
Shoemaker Daniel D Chief Scientific Officer 10/13/2017 48,346
Shoemaker Daniel D Chief Scientific Officer 10/16/2017 2,856
Storgard Chris Chief Medical Officer 11/23/2016 99,997
RASTETTER WILLIAM H Director 11/23/2016 999,998
Coughlin Timothy P Director 11/23/2016 149,997
Wolchko J Scott President and CEO 08/23/2016 3,521
Wolchko J Scott President and CEO 01/18/2016 11,238
Wolchko J Scott See Remarks 04/13/2015 11,723
Weyer Christian See Remarks 04/13/2015 34,250
Flynn Peter D See remarks 06/11/2014 1,658
Flynn Peter D See remarks 06/12/2014 8,808
Flynn Peter D See remarks 06/11/2014 7,119
Flynn Peter D See remarks 06/12/2014 38,297
Flynn Peter D See remarks 06/10/2014 1,139
Flynn Peter D See remarks 06/09/2014 2,054
Flynn Peter D See remarks 06/10/2014 9,450
Flynn Peter D See remarks 06/09/2014 13,685
Flynn Peter D See remarks 05/01/2014 40,977
Flynn Peter D See remarks 05/01/2014 207,598
Flynn Peter D See remarks 04/04/2014 9,599
Flynn Peter D See remarks 04/04/2014 47,109
Wolchko J Scott See remarks 04/03/2014 12,141
Weyer Christian See remarks 04/01/2014 10,601
Weyer Christian See remarks 04/02/2014 3,099
Weyer Christian See remarks 04/02/2014 20,395
Weyer Christian See remarks 04/01/2014 69,789
Shoemaker Daniel D Chief Technology Officer 03/31/2014 85,361
Flynn Peter D See remarks 04/01/2014 12,177
Flynn Peter D See remarks 03/31/2014 27,348
Wolchko J Scott See remarks 04/01/2014 36,482
Wolchko J Scott See remarks 03/31/2014 156,397
VENROCK ASSOCIATES V LP 10% Owner 10/04/2013 770,682
VENROCK ASSOCIATES V LP 10% Owner 10/04/2013 4,999,998
Polaris Venture Management Co. V, L.L.C. 10% Owner 10/04/2013 7,434
Polaris Venture Management Co. V, L.L.C. 10% Owner 10/04/2013 5,094
Polaris Venture Management Co. V, L.L.C. 10% Owner 10/04/2013 14,490
Polaris Venture Management Co. V, L.L.C. 10% Owner 10/04/2013 743,658
Polaris Venture Management Co. V, L.L.C. 10% Owner 10/04/2013 48,246
Polaris Venture Management Co. V, L.L.C. 10% Owner 10/04/2013 33,048
Polaris Venture Management Co. V, L.L.C. 10% Owner 10/04/2013 94,032
Polaris Venture Management Co. V, L.L.C. 10% Owner 10/04/2013 4,824,672
Nashat Amir Director 10/04/2013 7,434
Nashat Amir Director 10/04/2013 5,094
Nashat Amir Director 10/04/2013 14,490
Nashat Amir Director 10/04/2013 743,658
Nashat Amir Director 10/04/2013 48,246
Nashat Amir Director 10/04/2013 33,048
Nashat Amir Director 10/04/2013 94,032
Nashat Amir Director 10/04/2013 4,824,672
OVP VENTURE PARTNERS VII LP 10% Owner 10/04/2013 4,932
OVP VENTURE PARTNERS VII LP 10% Owner 10/04/2013 699,774
ARCH VENTURE FUND VI LP 10% Owner 10/04/2013 770,682
ARCH VENTURE FUND VI LP 10% Owner 10/04/2013 4,999,998
NELSEN ROBERT Director 10/04/2013 770,682
NELSEN ROBERT Director 10/04/2013 4,999,998
RASTETTER WILLIAM H Director 10/04/2013 499,998
MENDLEIN JOHN Director 10/04/2013 100,002
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2021
03/31/2021
0.48%
1Q
06/30/2021
12/31/2020
13.95%
2Q
06/30/2021
03/31/2020
23.71%
5Q
06/30/2021
12/31/2019
37.68%
6Q
Load More

Period of Report: 06/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
0.48%
1Q
12/31/2020
13.95%
2Q
03/31/2020
23.71%
5Q
12/31/2019
37.68%
6Q
Load More